Cancer is now a common life-course experience worldwide, responsible for more than 10 million deaths annually and affecting a large share of populations. In the UK, roughly 170,000 deaths per year are due to cancer and nearly half of people will experience cancer in their lifetime. Despite cancer’s ubiquity, outcomes and experiences are not equally distributed: socio-economic inequalities affect incidence, diagnosis, treatment, survivorship and end-of-life care.
This perspective argues that research and practice must look beyond individual behavioural risk factors to the broader social, economic and cultural contexts that shape cancer across the whole care pathway. It outlines how socio-economic position influences the risk of developing cancer and the effectiveness of prevention, detection and clinical care, and ends with practical implications for clinicians and services.
Health inequalities are systematic, socially produced, and avoidable differences in health between social groups defined by income, occupation, education, place, ethnicity, gender, disability or sexuality. In the UK and Europe the preferred term is health inequalities (other contexts may use ‘health disparities’ or ‘health inequities’). These inequalities are not limited to contrasts between the most and least advantaged; they form a gradient in which poorer socio-economic position is associated with worse health, higher age-specific mortality and shorter life expectancy.
Inequalities intersect across multiple axes: socio-economic status coexists with differences in ethnicity, place, gender and other social categories to produce complex patterns of advantage and disadvantage. These intersectional experiences influence exposures, access to resources and psychosocial states that matter for cancer risk and outcomes.
Socio-economic inequalities are evident at every stage of the cancer continuum. The authors frame the problem across five linked areas: (1) risk of developing cancer; (2) effectiveness of prevention, detection and diagnosis; (3) treatment; (4) survivorship; and (5) access to palliative care. Historically, most research has concentrated on epidemiological descriptions or on behavioural and service access pathways; comparatively less attention has been paid to how broader socio-economic forces operate across all stages.
Epidemiological studies demonstrate associations between lower socio-economic position and higher cancer incidence for many cancer sites. Area-level measures of deprivation and individual measures such as income and education both show relationships with cancer risk. Behavioural risk factors (for example, smoking and diet) contribute, but they are themselves patterned by social context and do not fully explain the socio-economic gradient in cancer incidence.
Prevention and early detection strategies do not perform uniformly across social groups. Differences in exposure to risk factors, health literacy, access to screening and primary care, and the wider social context influence the effectiveness of preventive interventions and the timeliness of diagnosis. The evidence base to date has largely emphasized timely access to services, but there has been less systematic attention to how socio-economic context modifies the impact of prevention and detection efforts.
Treatment effectiveness and clinical outcomes show socio-economic variation. In the UK, cancer mortality is about 60% higher in the most deprived areas compared with the least deprived; for all cancers combined this has been estimated to equate to over 28,000 deprivation-associated cancer deaths per year. The cancer–deprivation gap is apparent across multiple cancer sites and is particularly pronounced — and widening — for lung cancer, where mortality in the most deprived areas can be almost three times that in the least deprived areas. Similar area-based inequalities have been documented in other high-income settings.
Survivorship experiences and outcomes are also shaped by socio-economic conditions. Access to rehabilitation, financial protection, employment support and long-term follow-up varies by social position, influencing quality of life and long-term prognosis. The literature indicates that survivorship inequalities are part of the same gradient that affects earlier cancer stages.
Inequalities extend to end-of-life care. Socio-economic position influences access to palliative services, the quality of support received, and the broader social resources available to patients and families. Failure to examine these disparities across palliative care perpetuates inequities in the final phase of the cancer trajectory.
The scientific consensus explained in this perspective locates the causes of health inequalities in the social determinants of health — the conditions in which people are born, grow, live, work and age. These determinants operate across multiple levels:
These multi-level determinants influence exposures to pathogenic conditions (for example, poor housing, hazardous work) and limit access to salutogenic resources (for example, well-rewarded employment, good-quality services), thus shaping cancer risk and outcomes.
The authors contend that clinicians and cancer services should widen their frame of understanding beyond individual behaviours and immediate service factors to include socio-economic and structural influences. A stronger awareness of the pervasive role of social determinants can help clinicians identify barriers to equitable prevention, timely diagnosis and optimal treatment, and inform service redesign and advocacy.
Although the perspective does not provide a detailed implementation roadmap, it recommends applying insights from the broader health inequalities literature to the cancer continuum: consider social context when interpreting risk and response to interventions; assess and address barriers to access and adherence; and work collaboratively with public health, social care and policy actors to reduce upstream inequalities.
Cancer outcomes are deeply shaped by socio-economic inequalities that span the entire cancer continuum. Reducing the unequal burden of cancer requires moving beyond individual behavioural explanations to address the social determinants that structure risk, access, treatment and survivorship. Greater integration of socio-economic perspectives into clinical practice, research and policy is essential to improve equity in cancer care and outcomes.